nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC6A14—female reproductive system—urinary bladder cancer	0.0243	0.164	CbGeAlD
Valaciclovir—SLC22A8—urine—urinary bladder cancer	0.0224	0.152	CbGeAlD
Valaciclovir—SLC10A2—renal system—urinary bladder cancer	0.0197	0.134	CbGeAlD
Valaciclovir—SLC10A2—vagina—urinary bladder cancer	0.0143	0.0967	CbGeAlD
Valaciclovir—SLC15A1—epithelium—urinary bladder cancer	0.00823	0.0558	CbGeAlD
Valaciclovir—SLC22A8—prostate gland—urinary bladder cancer	0.00806	0.0546	CbGeAlD
Valaciclovir—SLC15A1—renal system—urinary bladder cancer	0.00764	0.0518	CbGeAlD
Valaciclovir—SLC15A2—prostate gland—urinary bladder cancer	0.007	0.0475	CbGeAlD
Valaciclovir—SLC15A2—seminal vesicle—urinary bladder cancer	0.00592	0.0402	CbGeAlD
Valaciclovir—SLC15A1—vagina—urinary bladder cancer	0.00553	0.0375	CbGeAlD
Valaciclovir—SLC22A8—renal system—urinary bladder cancer	0.00549	0.0372	CbGeAlD
Valaciclovir—SLC15A2—renal system—urinary bladder cancer	0.00477	0.0324	CbGeAlD
Valaciclovir—SLC15A2—urethra—urinary bladder cancer	0.00469	0.0318	CbGeAlD
Valaciclovir—SLC15A2—female reproductive system—urinary bladder cancer	0.00382	0.0259	CbGeAlD
Valaciclovir—SLC15A2—vagina—urinary bladder cancer	0.00346	0.0234	CbGeAlD
Valaciclovir—SLC6A14—Amine compound SLC transporters—SLC14A2—urinary bladder cancer	0.00326	0.217	CbGpPWpGaD
Valaciclovir—SLC15A2—lymph node—urinary bladder cancer	0.00224	0.0152	CbGeAlD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00128	0.0848	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000841	0.0559	CbGpPWpGaD
Valaciclovir—Dizziness—Thiotepa—urinary bladder cancer	0.000745	0.00089	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000742	0.000886	CcSEcCtD
Valaciclovir—Stomatitis—Methotrexate—urinary bladder cancer	0.000741	0.000885	CcSEcCtD
Valaciclovir—Urticaria—Fluorouracil—urinary bladder cancer	0.00074	0.000884	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—urinary bladder cancer	0.000738	0.000882	CcSEcCtD
Valaciclovir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000737	0.00088	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000728	0.00087	CcSEcCtD
Valaciclovir—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000728	0.000869	CcSEcCtD
Valaciclovir—Paraesthesia—Etoposide—urinary bladder cancer	0.000727	0.000868	CcSEcCtD
Valaciclovir—Haematuria—Methotrexate—urinary bladder cancer	0.000725	0.000866	CcSEcCtD
Valaciclovir—Dyspnoea—Etoposide—urinary bladder cancer	0.000722	0.000862	CcSEcCtD
Valaciclovir—Somnolence—Etoposide—urinary bladder cancer	0.00072	0.000859	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000719	0.000859	CcSEcCtD
Valaciclovir—Vomiting—Thiotepa—urinary bladder cancer	0.000716	0.000856	CcSEcCtD
Valaciclovir—Rash—Thiotepa—urinary bladder cancer	0.000711	0.000848	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—urinary bladder cancer	0.00071	0.000848	CcSEcCtD
Valaciclovir—Dermatitis—Thiotepa—urinary bladder cancer	0.00071	0.000848	CcSEcCtD
Valaciclovir—Headache—Thiotepa—urinary bladder cancer	0.000706	0.000843	CcSEcCtD
Valaciclovir—Decreased appetite—Etoposide—urinary bladder cancer	0.000704	0.00084	CcSEcCtD
Valaciclovir—Renal failure—Epirubicin—urinary bladder cancer	0.000699	0.000835	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000699	0.000835	CcSEcCtD
Valaciclovir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000698	0.000834	CcSEcCtD
Valaciclovir—Fatigue—Etoposide—urinary bladder cancer	0.000698	0.000833	CcSEcCtD
Valaciclovir—Stomatitis—Epirubicin—urinary bladder cancer	0.000693	0.000828	CcSEcCtD
Valaciclovir—Pain—Etoposide—urinary bladder cancer	0.000692	0.000827	CcSEcCtD
Valaciclovir—Constipation—Etoposide—urinary bladder cancer	0.000692	0.000827	CcSEcCtD
Valaciclovir—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000692	0.000826	CcSEcCtD
Valaciclovir—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000687	0.00082	CcSEcCtD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000686	0.000819	CcSEcCtD
Valaciclovir—Hepatitis—Methotrexate—urinary bladder cancer	0.000682	0.000815	CcSEcCtD
Valaciclovir—Asthenia—Gemcitabine—urinary bladder cancer	0.00068	0.000812	CcSEcCtD
Valaciclovir—Haematuria—Epirubicin—urinary bladder cancer	0.000678	0.00081	CcSEcCtD
Valaciclovir—Pharyngitis—Methotrexate—urinary bladder cancer	0.000677	0.000809	CcSEcCtD
Valaciclovir—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000674	0.000805	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000674	0.000805	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000673	0.000803	CcSEcCtD
Valaciclovir—Pruritus—Gemcitabine—urinary bladder cancer	0.000671	0.000801	CcSEcCtD
Valaciclovir—Nausea—Thiotepa—urinary bladder cancer	0.000669	0.000799	CcSEcCtD
Valaciclovir—Urethral disorder—Methotrexate—urinary bladder cancer	0.000669	0.000799	CcSEcCtD
Valaciclovir—Sinusitis—Epirubicin—urinary bladder cancer	0.000667	0.000797	CcSEcCtD
Valaciclovir—Feeling abnormal—Etoposide—urinary bladder cancer	0.000667	0.000797	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000662	0.00079	CcSEcCtD
Valaciclovir—Pruritus—Fluorouracil—urinary bladder cancer	0.000659	0.000787	CcSEcCtD
Valaciclovir—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000651	0.000777	CcSEcCtD
Valaciclovir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000649	0.000775	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—urinary bladder cancer	0.000647	0.000773	CcSEcCtD
Valaciclovir—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000645	0.000771	CcSEcCtD
Valaciclovir—Urticaria—Etoposide—urinary bladder cancer	0.000643	0.000768	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—urinary bladder cancer	0.000642	0.000766	CcSEcCtD
Valaciclovir—Rhinitis—Epirubicin—urinary bladder cancer	0.00064	0.000765	CcSEcCtD
Valaciclovir—Abdominal pain—Etoposide—urinary bladder cancer	0.00064	0.000764	CcSEcCtD
Valaciclovir—Body temperature increased—Etoposide—urinary bladder cancer	0.00064	0.000764	CcSEcCtD
Valaciclovir—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00064	0.000764	CcSEcCtD
Valaciclovir—Hepatitis—Epirubicin—urinary bladder cancer	0.000639	0.000763	CcSEcCtD
Valaciclovir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000638	0.000762	CcSEcCtD
Valaciclovir—Asthenia—Cisplatin—urinary bladder cancer	0.000634	0.000757	CcSEcCtD
Valaciclovir—Pharyngitis—Epirubicin—urinary bladder cancer	0.000634	0.000757	CcSEcCtD
Valaciclovir—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000631	0.000753	CcSEcCtD
Valaciclovir—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000629	0.000751	CcSEcCtD
Valaciclovir—Haematuria—Doxorubicin—urinary bladder cancer	0.000628	0.000749	CcSEcCtD
Valaciclovir—Urethral disorder—Epirubicin—urinary bladder cancer	0.000626	0.000748	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000623	0.000743	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—urinary bladder cancer	0.000618	0.000737	CcSEcCtD
Valaciclovir—Immune system disorder—Methotrexate—urinary bladder cancer	0.000616	0.000736	CcSEcCtD
Valaciclovir—Dizziness—Fluorouracil—urinary bladder cancer	0.000616	0.000736	CcSEcCtD
Valaciclovir—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000615	0.000734	CcSEcCtD
Valaciclovir—Chills—Methotrexate—urinary bladder cancer	0.000612	0.000731	CcSEcCtD
Valaciclovir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000605	0.000722	CcSEcCtD
Valaciclovir—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000604	0.000721	CcSEcCtD
Valaciclovir—Alopecia—Methotrexate—urinary bladder cancer	0.000603	0.00072	CcSEcCtD
Valaciclovir—Vomiting—Gemcitabine—urinary bladder cancer	0.000603	0.00072	CcSEcCtD
Valaciclovir—Rash—Gemcitabine—urinary bladder cancer	0.000598	0.000714	CcSEcCtD
Valaciclovir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000597	0.000713	CcSEcCtD
Valaciclovir—Hypersensitivity—Etoposide—urinary bladder cancer	0.000596	0.000712	CcSEcCtD
Valaciclovir—Headache—Gemcitabine—urinary bladder cancer	0.000594	0.000709	CcSEcCtD
Valaciclovir—Vomiting—Fluorouracil—urinary bladder cancer	0.000593	0.000708	CcSEcCtD
Valaciclovir—Rhinitis—Doxorubicin—urinary bladder cancer	0.000592	0.000707	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—urinary bladder cancer	0.000591	0.000706	CcSEcCtD
Valaciclovir—Rash—Fluorouracil—urinary bladder cancer	0.000588	0.000702	CcSEcCtD
Valaciclovir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000587	0.000701	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000587	0.0007	CcSEcCtD
Valaciclovir—Headache—Fluorouracil—urinary bladder cancer	0.000584	0.000697	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000584	0.000697	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000582	0.000695	CcSEcCtD
Valaciclovir—Asthenia—Etoposide—urinary bladder cancer	0.000581	0.000694	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00058	0.0385	CbGpPWpGaD
Valaciclovir—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000579	0.000692	CcSEcCtD
Valaciclovir—Immune system disorder—Epirubicin—urinary bladder cancer	0.000577	0.000689	CcSEcCtD
Valaciclovir—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000576	0.000687	CcSEcCtD
Valaciclovir—Back pain—Methotrexate—urinary bladder cancer	0.000575	0.000686	CcSEcCtD
Valaciclovir—Chills—Epirubicin—urinary bladder cancer	0.000573	0.000684	CcSEcCtD
Valaciclovir—Pruritus—Etoposide—urinary bladder cancer	0.000573	0.000684	CcSEcCtD
Valaciclovir—Alopecia—Epirubicin—urinary bladder cancer	0.000564	0.000674	CcSEcCtD
Valaciclovir—Nausea—Gemcitabine—urinary bladder cancer	0.000563	0.000672	CcSEcCtD
Valaciclovir—Vomiting—Cisplatin—urinary bladder cancer	0.000562	0.000671	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000559	0.000667	CcSEcCtD
Valaciclovir—Rash—Cisplatin—urinary bladder cancer	0.000557	0.000665	CcSEcCtD
Valaciclovir—Dermatitis—Cisplatin—urinary bladder cancer	0.000557	0.000665	CcSEcCtD
Valaciclovir—Diarrhoea—Etoposide—urinary bladder cancer	0.000554	0.000661	CcSEcCtD
Valaciclovir—Nausea—Fluorouracil—urinary bladder cancer	0.000554	0.000661	CcSEcCtD
Valaciclovir—Anaemia—Methotrexate—urinary bladder cancer	0.000549	0.000656	CcSEcCtD
Valaciclovir—Flatulence—Epirubicin—urinary bladder cancer	0.000548	0.000654	CcSEcCtD
Valaciclovir—Tension—Epirubicin—urinary bladder cancer	0.000546	0.000651	CcSEcCtD
Valaciclovir—Nervousness—Epirubicin—urinary bladder cancer	0.00054	0.000645	CcSEcCtD
Valaciclovir—Back pain—Epirubicin—urinary bladder cancer	0.000538	0.000642	CcSEcCtD
Valaciclovir—Dizziness—Etoposide—urinary bladder cancer	0.000535	0.000639	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000534	0.000637	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000533	0.000636	CcSEcCtD
Valaciclovir—Leukopenia—Methotrexate—urinary bladder cancer	0.000532	0.000635	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—urinary bladder cancer	0.00053	0.000633	CcSEcCtD
Valaciclovir—Nausea—Cisplatin—urinary bladder cancer	0.000525	0.000627	CcSEcCtD
Valaciclovir—Alopecia—Doxorubicin—urinary bladder cancer	0.000522	0.000624	CcSEcCtD
Valaciclovir—Cough—Methotrexate—urinary bladder cancer	0.000518	0.000619	CcSEcCtD
Valaciclovir—Convulsion—Methotrexate—urinary bladder cancer	0.000515	0.000615	CcSEcCtD
Valaciclovir—Vomiting—Etoposide—urinary bladder cancer	0.000515	0.000615	CcSEcCtD
Valaciclovir—Anaemia—Epirubicin—urinary bladder cancer	0.000514	0.000614	CcSEcCtD
Valaciclovir—Agitation—Epirubicin—urinary bladder cancer	0.000511	0.00061	CcSEcCtD
Valaciclovir—Rash—Etoposide—urinary bladder cancer	0.00051	0.000609	CcSEcCtD
Valaciclovir—Dermatitis—Etoposide—urinary bladder cancer	0.00051	0.000609	CcSEcCtD
Valaciclovir—Headache—Etoposide—urinary bladder cancer	0.000507	0.000606	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—urinary bladder cancer	0.000507	0.000605	CcSEcCtD
Valaciclovir—Chest pain—Methotrexate—urinary bladder cancer	0.000506	0.000604	CcSEcCtD
Valaciclovir—Myalgia—Methotrexate—urinary bladder cancer	0.000506	0.000604	CcSEcCtD
Valaciclovir—Arthralgia—Methotrexate—urinary bladder cancer	0.000506	0.000604	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—urinary bladder cancer	0.000505	0.000603	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000502	0.0006	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—urinary bladder cancer	0.0005	0.000597	CcSEcCtD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000498	0.0331	CbGpPWpGaD
Valaciclovir—Leukopenia—Epirubicin—urinary bladder cancer	0.000498	0.000594	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—urinary bladder cancer	0.000498	0.000594	CcSEcCtD
Valaciclovir—Confusional state—Methotrexate—urinary bladder cancer	0.000489	0.000584	CcSEcCtD
Valaciclovir—Cough—Epirubicin—urinary bladder cancer	0.000485	0.000579	CcSEcCtD
Valaciclovir—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000485	0.000579	CcSEcCtD
Valaciclovir—Convulsion—Epirubicin—urinary bladder cancer	0.000482	0.000575	CcSEcCtD
Valaciclovir—Infection—Methotrexate—urinary bladder cancer	0.000482	0.000575	CcSEcCtD
Valaciclovir—Nausea—Etoposide—urinary bladder cancer	0.000481	0.000574	CcSEcCtD
Valaciclovir—Hypertension—Epirubicin—urinary bladder cancer	0.00048	0.000573	CcSEcCtD
Valaciclovir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000475	0.000568	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—urinary bladder cancer	0.000475	0.000568	CcSEcCtD
Valaciclovir—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000475	0.000567	CcSEcCtD
Valaciclovir—Myalgia—Epirubicin—urinary bladder cancer	0.000473	0.000565	CcSEcCtD
Valaciclovir—Chest pain—Epirubicin—urinary bladder cancer	0.000473	0.000565	CcSEcCtD
Valaciclovir—Arthralgia—Epirubicin—urinary bladder cancer	0.000473	0.000565	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—urinary bladder cancer	0.000473	0.000565	CcSEcCtD
Valaciclovir—Skin disorder—Methotrexate—urinary bladder cancer	0.000471	0.000562	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.00047	0.000561	CcSEcCtD
Valaciclovir—Dry mouth—Epirubicin—urinary bladder cancer	0.000463	0.000553	CcSEcCtD
Valaciclovir—Anorexia—Methotrexate—urinary bladder cancer	0.000462	0.000552	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—urinary bladder cancer	0.00046	0.00055	CcSEcCtD
Valaciclovir—Confusional state—Epirubicin—urinary bladder cancer	0.000458	0.000546	CcSEcCtD
Valaciclovir—Oedema—Epirubicin—urinary bladder cancer	0.000454	0.000542	CcSEcCtD
Valaciclovir—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000454	0.000542	CcSEcCtD
Valaciclovir—Infection—Epirubicin—urinary bladder cancer	0.000451	0.000538	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—urinary bladder cancer	0.000449	0.000536	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—urinary bladder cancer	0.000446	0.000532	CcSEcCtD
Valaciclovir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000445	0.000531	CcSEcCtD
Valaciclovir—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000444	0.000531	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—urinary bladder cancer	0.000444	0.00053	CcSEcCtD
Valaciclovir—Tachycardia—Epirubicin—urinary bladder cancer	0.000443	0.000529	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000442	0.000527	CcSEcCtD
Valaciclovir—Skin disorder—Epirubicin—urinary bladder cancer	0.000441	0.000526	CcSEcCtD
Valaciclovir—Insomnia—Methotrexate—urinary bladder cancer	0.000439	0.000524	CcSEcCtD
Valaciclovir—Chest pain—Doxorubicin—urinary bladder cancer	0.000438	0.000523	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—urinary bladder cancer	0.000438	0.000523	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—urinary bladder cancer	0.000438	0.000523	CcSEcCtD
Valaciclovir—Paraesthesia—Methotrexate—urinary bladder cancer	0.000435	0.00052	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000435	0.000519	CcSEcCtD
Valaciclovir—Anorexia—Epirubicin—urinary bladder cancer	0.000433	0.000516	CcSEcCtD
Valaciclovir—Dyspnoea—Methotrexate—urinary bladder cancer	0.000432	0.000516	CcSEcCtD
Valaciclovir—Somnolence—Methotrexate—urinary bladder cancer	0.000431	0.000515	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—urinary bladder cancer	0.000428	0.000511	CcSEcCtD
Valaciclovir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000427	0.00051	CcSEcCtD
Valaciclovir—Confusional state—Doxorubicin—urinary bladder cancer	0.000423	0.000506	CcSEcCtD
Valaciclovir—Decreased appetite—Methotrexate—urinary bladder cancer	0.000421	0.000503	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—urinary bladder cancer	0.00042	0.000501	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00042	0.000501	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000419	0.0005	CcSEcCtD
Valaciclovir—Fatigue—Methotrexate—urinary bladder cancer	0.000418	0.000499	CcSEcCtD
Valaciclovir—Infection—Doxorubicin—urinary bladder cancer	0.000417	0.000498	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000416	0.0276	CbGpPWpGaD
Valaciclovir—Pain—Methotrexate—urinary bladder cancer	0.000415	0.000495	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000413	0.000494	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000412	0.000492	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000411	0.000491	CcSEcCtD
Valaciclovir—Insomnia—Epirubicin—urinary bladder cancer	0.00041	0.00049	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—urinary bladder cancer	0.00041	0.000489	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000408	0.000487	CcSEcCtD
Valaciclovir—Paraesthesia—Epirubicin—urinary bladder cancer	0.000407	0.000487	CcSEcCtD
Valaciclovir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000405	0.000483	CcSEcCtD
Valaciclovir—Somnolence—Epirubicin—urinary bladder cancer	0.000403	0.000482	CcSEcCtD
Valaciclovir—Anorexia—Doxorubicin—urinary bladder cancer	0.0004	0.000478	CcSEcCtD
Valaciclovir—Feeling abnormal—Methotrexate—urinary bladder cancer	0.0004	0.000477	CcSEcCtD
Valaciclovir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000399	0.000477	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000396	0.000473	CcSEcCtD
Valaciclovir—Decreased appetite—Epirubicin—urinary bladder cancer	0.000394	0.000471	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000392	0.000468	CcSEcCtD
Valaciclovir—Fatigue—Epirubicin—urinary bladder cancer	0.000391	0.000467	CcSEcCtD
Valaciclovir—Constipation—Epirubicin—urinary bladder cancer	0.000388	0.000463	CcSEcCtD
Valaciclovir—Pain—Epirubicin—urinary bladder cancer	0.000388	0.000463	CcSEcCtD
Valaciclovir—Urticaria—Methotrexate—urinary bladder cancer	0.000385	0.00046	CcSEcCtD
Valaciclovir—Abdominal pain—Methotrexate—urinary bladder cancer	0.000383	0.000458	CcSEcCtD
Valaciclovir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000383	0.000458	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000383	0.000457	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—urinary bladder cancer	0.00038	0.000453	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000377	0.00045	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000374	0.000447	CcSEcCtD
Valaciclovir—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000374	0.000446	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—urinary bladder cancer	0.000373	0.000446	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000371	0.000443	CcSEcCtD
Valaciclovir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00037	0.000441	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000365	0.000436	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000362	0.000433	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—urinary bladder cancer	0.000362	0.000432	CcSEcCtD
Valaciclovir—Urticaria—Epirubicin—urinary bladder cancer	0.00036	0.00043	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—urinary bladder cancer	0.000359	0.000429	CcSEcCtD
Valaciclovir—Constipation—Doxorubicin—urinary bladder cancer	0.000359	0.000429	CcSEcCtD
Valaciclovir—Abdominal pain—Epirubicin—urinary bladder cancer	0.000359	0.000428	CcSEcCtD
Valaciclovir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000359	0.000428	CcSEcCtD
Valaciclovir—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000357	0.000427	CcSEcCtD
Valaciclovir—Asthenia—Methotrexate—urinary bladder cancer	0.000348	0.000415	CcSEcCtD
Valaciclovir—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000346	0.000413	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000343	0.00041	CcSEcCtD
Valaciclovir—Pruritus—Methotrexate—urinary bladder cancer	0.000343	0.00041	CcSEcCtD
Valaciclovir—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000334	0.000399	CcSEcCtD
Valaciclovir—Urticaria—Doxorubicin—urinary bladder cancer	0.000334	0.000398	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000332	0.000396	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000332	0.000396	CcSEcCtD
Valaciclovir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000332	0.000396	CcSEcCtD
Valaciclovir—Asthenia—Epirubicin—urinary bladder cancer	0.000326	0.000389	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—NQO1—urinary bladder cancer	0.000325	0.0216	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000322	0.0214	CbGpPWpGaD
Valaciclovir—Pruritus—Epirubicin—urinary bladder cancer	0.000321	0.000383	CcSEcCtD
Valaciclovir—Dizziness—Methotrexate—urinary bladder cancer	0.000321	0.000383	CcSEcCtD
Valaciclovir—Diarrhoea—Epirubicin—urinary bladder cancer	0.00031	0.000371	CcSEcCtD
Valaciclovir—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000309	0.000369	CcSEcCtD
Valaciclovir—Vomiting—Methotrexate—urinary bladder cancer	0.000308	0.000368	CcSEcCtD
Valaciclovir—Rash—Methotrexate—urinary bladder cancer	0.000306	0.000365	CcSEcCtD
Valaciclovir—Dermatitis—Methotrexate—urinary bladder cancer	0.000305	0.000365	CcSEcCtD
Valaciclovir—Headache—Methotrexate—urinary bladder cancer	0.000304	0.000363	CcSEcCtD
Valaciclovir—Asthenia—Doxorubicin—urinary bladder cancer	0.000301	0.00036	CcSEcCtD
Valaciclovir—Dizziness—Epirubicin—urinary bladder cancer	0.0003	0.000358	CcSEcCtD
Valaciclovir—Pruritus—Doxorubicin—urinary bladder cancer	0.000297	0.000355	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000295	0.0196	CbGpPWpGaD
Valaciclovir—Vomiting—Epirubicin—urinary bladder cancer	0.000288	0.000345	CcSEcCtD
Valaciclovir—Nausea—Methotrexate—urinary bladder cancer	0.000288	0.000344	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000287	0.000343	CcSEcCtD
Valaciclovir—Rash—Epirubicin—urinary bladder cancer	0.000286	0.000342	CcSEcCtD
Valaciclovir—Dermatitis—Epirubicin—urinary bladder cancer	0.000286	0.000341	CcSEcCtD
Valaciclovir—Headache—Epirubicin—urinary bladder cancer	0.000284	0.000339	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000279	0.0185	CbGpPWpGaD
Valaciclovir—Dizziness—Doxorubicin—urinary bladder cancer	0.000278	0.000332	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000274	0.0182	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—urinary bladder cancer	0.000271	0.018	CbGpPWpGaD
Valaciclovir—Nausea—Epirubicin—urinary bladder cancer	0.00027	0.000322	CcSEcCtD
Valaciclovir—Vomiting—Doxorubicin—urinary bladder cancer	0.000267	0.000319	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—urinary bladder cancer	0.000265	0.000316	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000264	0.000316	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—urinary bladder cancer	0.000263	0.000314	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000254	0.0169	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—urinary bladder cancer	0.000249	0.000298	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM1—urinary bladder cancer	0.000249	0.0165	CbGpPWpGaD
Valaciclovir—SLC10A2—Orphan transporters—CREBBP—urinary bladder cancer	0.000246	0.0163	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000244	0.0162	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000233	0.0155	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000226	0.015	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000213	0.0141	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00019	0.0126	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000189	0.0125	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000174	0.0115	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTZ1—urinary bladder cancer	0.000159	0.0106	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTO2—urinary bladder cancer	0.000151	0.01	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAT1—urinary bladder cancer	0.000151	0.01	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000148	0.00986	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000139	0.00926	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—UGT2B7—urinary bladder cancer	0.000138	0.00917	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000129	0.00859	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000128	0.00852	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP4B1—urinary bladder cancer	0.000124	0.00825	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC19A1—urinary bladder cancer	0.000117	0.00779	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000117	0.00779	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000115	0.00764	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PRSS3—urinary bladder cancer	0.000114	0.0076	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000101	0.00669	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	9.6e-05	0.00638	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	9.35e-05	0.00621	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.16e-05	0.00609	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TYMP—urinary bladder cancer	9.14e-05	0.00607	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.78e-05	0.00583	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.31e-05	0.00552	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NAT2—urinary bladder cancer	8.26e-05	0.00549	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.21e-05	0.00546	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.62e-05	0.00506	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—RRM2—urinary bladder cancer	7.13e-05	0.00474	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.94e-05	0.00461	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.78e-05	0.0045	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—HPGDS—urinary bladder cancer	6.61e-05	0.00439	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ENO2—urinary bladder cancer	6.61e-05	0.00439	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.57e-05	0.00436	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTT1—urinary bladder cancer	6.41e-05	0.00426	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.31e-05	0.00419	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6e-05	0.00399	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.66e-05	0.00376	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.55e-05	0.00368	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.49e-05	0.00365	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NQO1—urinary bladder cancer	5.33e-05	0.00354	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.17e-05	0.00343	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.15e-05	0.00342	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.58e-05	0.00304	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.51e-05	0.00299	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—urinary bladder cancer	4.44e-05	0.00295	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.3e-05	0.00286	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—TYMS—urinary bladder cancer	4.13e-05	0.00274	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—urinary bladder cancer	4.08e-05	0.00271	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—NCOR1—urinary bladder cancer	4.08e-05	0.00271	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GPX1—urinary bladder cancer	3.91e-05	0.0026	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ERCC2—urinary bladder cancer	3.84e-05	0.00255	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.82e-05	0.00254	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—MTHFR—urinary bladder cancer	3.61e-05	0.0024	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPARG—urinary bladder cancer	2.93e-05	0.00194	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CREBBP—urinary bladder cancer	2.81e-05	0.00187	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.6e-05	0.00172	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.41e-05	0.0016	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—urinary bladder cancer	2.3e-05	0.00153	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.14e-05	0.00142	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—urinary bladder cancer	2.01e-05	0.00133	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—EP300—urinary bladder cancer	1.91e-05	0.00127	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.79e-05	0.00119	CbGpPWpGaD
